Academic literature on the topic 'Epidermal growth factor pathway'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Epidermal growth factor pathway.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Epidermal growth factor pathway"

1

Bonomi, Philip. "Epidermal Growth Factor Receptor Pathway." Journal of Thoracic Oncology 5, no. 12 (2010): S470—S471. http://dx.doi.org/10.1097/01.jto.0000391370.86753.90.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Baselga, Jose. "Epidermal growth factor receptor pathway inhibitors." Update on Cancer Therapeutics 1, no. 3 (2006): 299–310. http://dx.doi.org/10.1016/j.uct.2006.08.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Salcini, Anna Elisabetta, Hong Chen, Gioacchin Iannolo, Pietro De Camilli, and Pier Paolo Di Fiore. "Epidermal growth factor pathway substrate 15, Eps15." International Journal of Biochemistry & Cell Biology 31, no. 8 (1999): 805–9. http://dx.doi.org/10.1016/s1357-2725(99)00042-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Mingdi, Shizhong Cai, Bin Zuo, et al. "Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway." Tumor Biology 39, no. 5 (2017): 101042831769835. http://dx.doi.org/10.1177/1010428317698359.

Full text
Abstract:
Gallbladder cancer has poor prognosis and limited therapeutic options. Arctigenin, a representative dibenzylbutyrolactone lignan, occurs in a variety of plants. However, the molecular mechanisms involved in the antitumor effect of arctigenin on gallbladder cancer have not been fully elucidated. The expression levels of epidermal growth factor receptor were examined in 100 matched pairs of gallbladder cancer tissues. A positive correlation between high epidermal growth factor receptor expression levels and poor prognosis was observed in gallbladder cancer tissues. Pharmacological inhibition or
APA, Harvard, Vancouver, ISO, and other styles
5

Goffin, John R., and Kevin Zbuk. "Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline." Clinical Therapeutics 35, no. 9 (2013): 1282–303. http://dx.doi.org/10.1016/j.clinthera.2013.08.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dai, Chenyue, Bing Liu, Shaolei Li, et al. "Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance." Technology in Cancer Research & Treatment 20 (January 2021): 153303382110568. http://dx.doi.org/10.1177/15330338211056809.

Full text
Abstract:
Objectives: Epidermal growth factor receptor-tyrosine kinase inhibitors are widely used for lung epidermal growth factor receptor-positive lung adenocarcinomas, but acquired resistance is inevitable. Although non-coding RNAs, such as circular RNA and microRNA, are known to play vital roles in epidermal growth factor receptor-tyrosine kinase inhibitor resistance, comprehensive analysis is lacking. Thus, this study aimed to explore the circular RNA-microRNA-messenger RNA regulatory network involved in epidermal growth factor receptor-tyrosine kinase inhibitor resistance. Methods: To identify dif
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Lingling, Xiaoxue Zhang, and Liang Zhao. "Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor." Open Life Sciences 11, no. 1 (2016): 427–31. http://dx.doi.org/10.1515/biol-2016-0056.

Full text
Abstract:
AbstractThe EGFR signaling pathway plays an important role in the occurrence and development of many malignant tumors. It has become a hot spot in the treatment of advanced cancer. At present, the small molecule epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), has been shown to advanced non-small-cell lung cancer (NSCLC), has a marked drug resistance or has developed one. The EGFR signaling pathway regulates a variety of cellular functions, and its drug resistance may be related to a number of signal transduction pathways, including drug resistance mutations, structural a
APA, Harvard, Vancouver, ISO, and other styles
8

Brightman, Frances A., Simon Thomas, and David A. Fell. "Simulation of The Epidermal Growth Factor Signal Transduction Pathway." Biochemical Society Transactions 27, no. 1 (1999): A48. http://dx.doi.org/10.1042/bst027a048a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wakui, Shin, Masakuni Furusato, Mitsugu Tanaka, William C. Allsbrook, Yutaka Kano, and Shinichiro Ushigome. "Endothelium and pericyte interdigitation: Pathway for epidermal growth factor?" Microvascular Research 40, no. 2 (1990): 285–91. http://dx.doi.org/10.1016/0026-2862(90)90026-n.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chang, Jui-Yoa, Patrick Schindler, Ueli Ramseier, and Por-Hsiung Lai. "The Disulfide Folding Pathway of Human Epidermal Growth Factor." Journal of Biological Chemistry 270, no. 16 (1995): 9207–16. http://dx.doi.org/10.1074/jbc.270.16.9207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Epidermal growth factor pathway"

1

Mayawala, Kapil. "Spatiotemporal modeling of epidermal growth factor receptor signaling pathway." Access to citation, abstract and download form provided by ProQuest Information and Learning Company; downloadable PDF file 2.14 Mb., 263 p, 2006. http://wwwlib.umi.com/dissertations/fullcit/3220795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wasserman, Jonathan Daniel. "Pattern formation in Drosophila : roles of the EGF receptor pathway." Thesis, University of Cambridge, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.624214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kleiman, Laura B. "Experimental and computational analysis of epidermal growth factor receptor pathway phosphorylation dynamics." Thesis, Massachusetts Institute of Technology, 2010. http://hdl.handle.net/1721.1/57796.

Full text
Abstract:
Thesis (Ph. D.)--Massachusetts Institute of Technology, Computational and Systems Biology Program, 2010.<br>Cataloged from PDF version of thesis.<br>Includes bibliographical references (p. 157-168).<br>The epidermal growth factor receptor (EGFR, also known as ErbB 1) is a prototypical receptor tyrosine kinase (RTK) that activates multi-kinase phosphorylation cascades to regulate diverse cellular processes, including proliferation, migration and differentiation. ErbB 1 heterooligomerizes with three close homologues: ErbB2, ErbB3 and ErbB4. ErbB1-3 receptors are frequently mutated, overexpressed
APA, Harvard, Vancouver, ISO, and other styles
4

Ho, Ka-yan Rebecca Lucinda, and 何嘉茵. "Mutations of epidermal growth factor receptor (EGFR) pathway genes andMET in primary lung adenocarcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48333906.

Full text
Abstract:
This study completed the analysis of mutational frequencies and clinicopathological patterns of six EGFR pathway-related genes (EGFR, HER2, HER4, KRAS, BRAF and MET) in 212 resected lung adenocarcinomas (AD) from 98 male and 114 female Chinese patients without prior chemotherapy or tyrosine kinase inhibitor (TKI) therapy. Genomic DNA and cDNA sequencing, quantitative PCR and fluorescence in-situ hybridization (FISH) were employed to investigate mutation and amplification status of the relevant genes. Overall, more than 75% of tumours were detected to harbour mutations or amplification in one
APA, Harvard, Vancouver, ISO, and other styles
5

Jordan, Katherine C. "Patterning the Drosophila eggshell and embryo through the interaction of the epidermal growth factor receptor and notch pathways /." Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/5036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shea, Ka-hon Graham, and 佘嘉翰. "ErbB receptor modulation by the Notch pathway as a means to fate commitment in bone marrow-derived Schwann cells." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46083042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, Fangli 1968. "Characterization of split ends, a new component of the Drosophila epidermal growth factor receptor signaling pathway." Thesis, Massachusetts Institute of Technology, 2001. http://hdl.handle.net/1721.1/8579.

Full text
Abstract:
Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Biology, 2001.<br>Includes bibliographical references.<br>Split ends (spen) was isolated as a strong enhancer of the rough eye phenotype associated with constitutive activation of Yan, implicating spen as a positive regulator of the receptor tyrosine kinase (RTK) signaling pathway. Molecular characterization of spen has revealed that spen encodes a protein with 5476 amino acids. It contains three tandem repeats of an RNA Recognition Motif (RRM) at its N-terminus, suggesting that Spen might function as an RNAbinding protein. Spen a
APA, Harvard, Vancouver, ISO, and other styles
8

Davidson, Bruce Paul, University of Western Sydney, and School of Biological Sciences. "Compound mutations in the mammalian EGFR signalling pathway affect epidermal development, growth and viability." THESIS_XXXX_SBS_Davidson_B.xml, 1997. http://handle.uws.edu.au:8081/1959.7/518.

Full text
Abstract:
The widespread expression of polypeptide growth factors from the earliest stages of embryonic development through to mature issues in the adult organism suggests an involvement in a reiterated developmental process affecting the underlying cellular growth and differentiation of many tissues. The hair follicle has taken on increased significance with the observation that many genetic mutations in these peptide growth factor genes affect its development. The targeted disruption of genes encoding members of the EpidermalGrowth Factor (EGF) and Fibroblast Growth Factor (FGF) families in the mouse
APA, Harvard, Vancouver, ISO, and other styles
9

So, Kam-ting. "Mutations in epidermal growth factor receptor-related pathways in non-small cell lung cancer." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43085313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dai, Yumin. "Phytochemicals from Graviola fruit selectively inhibit breast cancer cells growth involving EGFR signaling pathway." Thesis, Virginia Tech, 2010. http://hdl.handle.net/10919/41892.

Full text
Abstract:
There is a growing interest in using naturally-occurring compounds as cancer chemopreventive or chemotherapeutic agents. This study investigated the anticancer potential of the graviola fruit extract (GFE) on specific human breast cancer (BC) cells. GFE was found in our preliminary screening to selectively inhibit the growth of certain human BC cells (MDA-MB-468) but did not affect non-transformed breast epithelial MCF-10A cells. GFE treatment was very effective against the growth of MDA-MB-468 BC cells with an IC50 of 4.8 µg/ml. In vitro, effects of GFE treatment on MDA-MB-468 BC cells were
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Epidermal growth factor pathway"

1

Tarun, Patel B., and Bertics J. Paul. Epidermal Growth Factor. Humana Press, 2005. http://dx.doi.org/10.1385/159745012x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1950-, Luger Thomas A., and Schwarz Thomas 1957-, eds. Epidermal growth factors and cytokines. M. Dekker, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1953-, Patel Tarun B., and Bertics Paul J, eds. Epidermal growth factor: Methods and protocols. Humana Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lindström, Annelie. Targeting to EGF receptors: Preparation of EGF-dextran conjugates and analysis of their metabolism in vitro and in vivo. Uppsala University, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Das, Manjusri. Selected abstracts on oncogenes and epidermal growth factor receptors. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mbai, Fiona Ndinda. Characterisation of murine endometrial epithelium in vitro: Effects of epidermal growth factor. University of Manchester, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Laato, Matti. The effect of epidermal growth factor on granulation tissue formation in the rat. University of Turku, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hodges, Nikolas John. Potentiation of epidermal growth factor mitogenicity by phenobarbitone in primary cultures of rat hepatocytes. University of Birmingham, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Reilly, Raymond Matthew. Epidermal growth factor receptor overexpression as a target for imaging and radiotherapy of breast cancer. National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Harding, Helen Louise. The regulation of PEPCK gene expression by insulin and epidermal growth factor in rat hepatocytes. University of Manchester, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Epidermal growth factor pathway"

1

Miki, Toru, Randa Hilal-Dandan, Laurence L. Brunton, et al. "Epidermal Growth Factor Receptor Pathway Substrate 8." In Encyclopedia of Signaling Molecules. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Milanesi, Francesca, Niels Volkmann, Giorgio Scita, and Dorit Hanein. "Eps8 (Epidermal Growth Factor Receptor Pathway Substrate 8)." In Encyclopedia of Signaling Molecules. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miki, Toru, Randa Hilal-Dandan, Laurence L. Brunton, et al. "Eps8 (Epidermal Growth Factor Receptor Pathway Substrate 8)." In Encyclopedia of Signaling Molecules. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ahn, Sun M., Seungwon Kim, and Jennifer R. Grandis. "Epidermal Growth Factor Receptor-Targeted Therapies." In Signaling Pathways in Squamous Cancer. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7203-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Henson, Elizabeth S., and Spencer B. Gibson. "Epidermal Growth Factor (EGF) Receptor Signaling and Cancer." In Signal Transduction: Pathways, Mechanisms and Diseases. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-02112-1_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Repertinger, Susan K., Justin G. Madson, Kyle J. Bichsel, and Laura A. Hansen. "The Epidermal Growth Factor Receptor in Normal and Neoplastic Epithelia." In Signaling Pathways in Squamous Cancer. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7203-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sorkin, Alexander, Elena Kornilova, and Sergey Krolenko. "Two Recycling Pathways of Epidermal Growth Factor-Receptor Complexes in A431 Cells." In Endocytosis. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-84295-5_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ciardiello, Fortunato, Teresa Troiani, and Giampaolo Tortora. "The Epidermal Growth Factor Receptor Pathway as a Selective Molecular-Targeted Treatment in Human Breast Cancer." In Biomarkers in Breast Cancer. Humana Press, 2006. http://dx.doi.org/10.1385/1-59259-915-x:177.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Roden, Dylan F., Jennifer M. Johnson, Petr Szturz, Paolo Bossi, and Athanassios Argiris. "New and Promising Targeted Therapies in First and Second-Line Settings." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_18.

Full text
Abstract:
AbstractDeeper understanding of the molecular pathogenesis of malignancies, including head and neck squamous cell carcinoma (HNSCC), has led to the investigation of several novel targeted therapies. These therapeutic approaches may eventually replace or complement existing treatment modalities, such as surgery, radiation therapy, and traditional cytotoxic chemotherapy. Epidermal growth factor receptor (EGFR) inhibitors, and specifically cetuximab, are as of now the only class of targeted agents, excluding immune checkpoint inhibitors, with approval in the treatment of HNSCC. Beyond EGFR inhibi
APA, Harvard, Vancouver, ISO, and other styles
10

Seo, Ean-Jeong, Ching-Fen Wu, Henny J. Greten, and Thomas Efferth. "Epidermal Growth Factor Receptors and Downstream Signalling Pathways as Cancer Treatment Targets for Medicinal Plants." In Ethnopharmacology. John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118930717.ch16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Epidermal growth factor pathway"

1

Codony-Servat, Jordi, Miguel Angel Molina-Vila, Jordi Bertran-Alamillo, Rafael Rosell, and Erik D’Hondt. "Abstract 2368: Inhibition of epidermal growth factor receptor pathway by epidermal growth factor antibodies in non-small cell lung cancer." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2368.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Allen, Fred D., Clara F. Asnes, Alan Wells, Elliot L. Elson, and Douglas A. Lauffenburger. "Alternative Pathways of Epidermal Growth Factor Receptor Mediated Contractile Force in NR6 Fibroblasts." In ASME 1999 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1999. http://dx.doi.org/10.1115/imece1999-0403.

Full text
Abstract:
Abstract We investigated the contractile force response to epidermal growth factor (EGF) stimulation in 3T3-derived NR6 fibroblast cells in order to determine significant pathways of biochemical signaling that mediate the response. We examined the force generating specificity of the EGF receptor (EGFR) signaling mechanism by using mutant NR6 fibroblasts expressing variations of the EGFR construct. The wild-type (WT) cell presented the complete internalizing EGFR signaling construct while the c’973 cell presented an internalization-defective EGFR construct, and the M721 cell presented a kinase-
APA, Harvard, Vancouver, ISO, and other styles
3

Reyes-Reyes, Elsa M., Francesca R. Salipur, and Paula J. Bates. "Abstract 1046: AS1411 activity is regulated by epidermal growth factor receptor signaling pathway." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-1046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fang, Hua, Yan Li, Yonghua Wang, and Shuwei Zhang. "Dynamic Model and Regulatory Mechanism of Integrated ERK Signal Pathway Activated by Epidermal Growth Factor." In 2008 Fourth International Conference on Natural Computation. IEEE, 2008. http://dx.doi.org/10.1109/icnc.2008.89.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Takahashi, Hirofumi, Jun Sakakibara-Konishi, Shotaro Ito, et al. "Abstract 1991: Notch pathway regulates proliferation of osimertinib drug-tolerant cells in epidermal growth factor receptor mutated non-small cell lung cancer." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1991.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kim, Eric S., Yuanqing Ye, Ara A. Vaporciyan, et al. "Abstract 1728: Genetic variations in epidermal growth factor receptor pathway predict recurrence and response to chemotherapy in early stage non-small cell lung cancer." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1728.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Katanasaka, Yasufumi, and Fumiaki Koizumi. "Abstract 3194: Epidermal growth factor receptor variant type III induces angiopoietin like 4 expression through mitogen activated protein kinase pathway and promotes tumor angiogenesis in malignant glioma." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hsu, Ya-Ting, Joseph Liu, Peter A. Binkley, et al. "Abstract 3326: Parallel EMT pathways mediated by epidermal growth factor, EpCAM and mesenchymal cadherins in benign endometriotic lesions and endometrial cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vassella, Erik. "Abstract 2370: miR-19b enhances proliferation and apoptosis resistance via the epidermal growth factor receptor signalling pathway by targeting PP2A and BIM in non-small cell lung cancer." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-2370.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Anand, Monika, Zendra E. Zehner, and Helen L. Fillmore. "Abstract 261: Epidermal growth factor receptor (EGFR)-mediated upregulation of matrix metalloproteinase-1(MMP-1) in glioblastoma cell lines involves multiple signaling pathways." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-261.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Epidermal growth factor pathway"

1

บุญรัตนกรกิจ, วิโรจน์. ตัวจับของโปรเจสเตอโรนหยุดยั้งการเติบโตของเซลล์มะเร็งปอดโดยการรบกวนการส่งสัญญาณของ Epidermal growth factor receptor (EGFR). จุฬาลงกรณ์มหาวิทยาลัย, 2016. https://doi.org/10.58837/chula.res.2016.42.

Full text
Abstract:
ในปัจจุบันเริ่มมีหลักฐานว่า progesterone receptor (PR) มีความเกี่ยวข้องกับมะเร็งปอดชนิด NSCLC อย่างไรก็ตามยังไม่มีการศึกษาเกี่ยวกับกลไกการส่งสัญญาณของ PR กับ NSCLC โดยจากการศึกษาที่ผ่านมาพบว่า PR มี Polyproline SH3 recognition motif (PXXPXR motif หรือ PPD) ที่สามารถจับกับ SH3 domain ของ signaling molecules ได้ ผู้วิจัยจึงตั้งสมมุติฐานว่า PXXPXR motif ของ PR สามารถขัดขวางการส่งสัญญาณของ EGFR ผ่าน MAPK และ/หรือ AKT pathway ในเซลล์มะเร็งปอดได้ ซึ่งจะส่งผลให้เซลล์มะเร็งปอดมีการเจริญเติบโตลดน้อยลง โดยทำการทดสอบบทบาทของ PXXPXR motif ในด้านการเจริญเติบโตและการส่งสัญญาณในเซลล์มะเร็งปอดที่มีการแสดงออกข
APA, Harvard, Vancouver, ISO, and other styles
2

Herlyn, Dorothee M. Targeting Mutated Epidermal Growth Factor Receptor. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada371205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Adamson, Eileen D. Epidermal Growth Factor-Like Ligands in Breast Cancer. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada366955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Adamson, Eileen D. Epidermal Growth Factor-Like Ligands in Breast Cancer. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300591.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Leung, F. L., J. F. Park, and G. E. Dagle. Epidermal growth factor receptor expression in radiation-induced dog lung tumors by immunocytochemical localization. Office of Scientific and Technical Information (OSTI), 1993. http://dx.doi.org/10.2172/10166499.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Muller, William J. Expression of the Epidermal Growth Factor Receptor Family in Transgenic Mouse Models of Human Breast Cancer. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

El-Ashry, Dorraya. Growth Factor Regulation of Estrogen Receptor Function - A Pathway to Estrogen Independence. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300628.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Siegfried, Jill. Targeting the Hepatocyte Growth Factor Pathway for the Treatment of Breast Cancer. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada383623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Woll, Steven. Insulin-like Growth Factor Pathway Described in Austrofundulus limnaeus Diapause and Escape Embryos. Portland State University Library, 2000. http://dx.doi.org/10.15760/etd.3198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

ธรรมรักษ์, เผด็จ. ปัจจัยที่มีอิทธิพลต่อผลผลิตน้ำนมเหลืองในแม่สุกร (ปีที่ 2). คณะสัตวแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2019. https://doi.org/10.58837/chula.res.2019.40.

Full text
Abstract:
ในช่วงทศวรรษที่ผ่านมา การผลิตสุกรในประเทศไทยกลายเป็นอุตสาหกรรมและจำนวนของลูกสุกรต่อ ครอกมีแนวโน้มเพิ่มขึ้นอย่างรวดเร็ว หนึ่งในปัจจัยสำคัญที่จะนำไปสู่ความสำเร็จใน “อุตสาหกรรมฟาร์มสุกร” คือ การจัดการการคลอดที่เหมาะสม โดยปัจจัยสำคัญที่จะนำไปสู่ความสำเร็จของการจัดการการคลอด ประกอบด้วย การจัดการกระบวนการคลอดของแม่สุกรอย่างเหมาะสม การช่วยเหลือแม่สุกรที่ต้องการความ ช่วยเหลือ และ การย้ายฝากลูกสุกรอย่างเหมาะสม แนวทางการจัดการเหล่านี้ได้รับความสนใจมากขึ้นในวงการ วิจัยสุกร เนื่องจากจำนวนลูกสุกรที่มีชีวิตต่อครอกเพิ่มขึ้นในกลุ่มแม่สุกรสายพันธุ์สมัยใหม่ “น้ำนมเหลือง” เป็น สิ่งคัดหลั่งสิ่งแรกที่ถูกผลิตออกมาจ
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!